Revealed: The full list of medicines withdrawn over allergy concerns and why
Pholcodine can trigger allergic reactions and is common in cough syrups
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Popular cough medicines are being withdrawn from sale over fears people may suffer a serious allergic reaction.
– What has happened?
Watchdog the Medicines and Healthcare products Regulatory Agency (MHRA) has ordered some products off the shelves over worries about the potential for people to suffer a rare allergic reaction.
It says cough medicines containing the ingredient pholcodine are being recalled and withdrawn from the UK “as a precaution”.
This follows assessment of the risk of “very rare” anaphylaxis – a major allergic reaction – when people who have taken pholcodine in the previous 12 months have a general anaesthetic with neuromuscular blocking agents (NMBA).
The MHRA said: “The available data has demonstrated that pholcodine use, particularly in the 12 months before general anaesthesia with NMBAs, is a risk factor for developing an anaphylactic reaction to NMBAs.”
– What are NMBAs?
Neuromuscular blocking drugs are also known as muscle relaxants and data suggests they are used in around half of general anaesthetics administered in the UK.
NMBAs block the transmission of signals between motor nerve endings and skeletal muscles, preventing the affected muscles from contracting.
One use is when a patient needs to be intubated, with the NMBA paralysing or relaxing the jaw and the vocal cords.
– Which products are being withdrawn?
The following products have been recalled:
Boots Night Cough Relief Oral Solution, PL 00014/0230
Boots Dry Cough Syrup 6 Years+, PL 00014/0523
Boots Day Cold & Flu Relief Oral Solution, PL 00014/0565
Cofsed Linctus, PL 00240/0097
Care Pholcodine 5mg/5ml Oral Solution Sugar Free, PL 00240/0101
Galenphol Linctus, PL 00240/0101
Galenphol Paediatric Linctus, PL 00240/0102
Galenphol Strong Linctus, PL 00240/0103
Covonia Dry Cough Sugar Free Formula, PL 00240/0353
Pholcodine Linctus Bells Healthcare 5mg Per 5ml Oral Solution, PL 03105/0059
Numark Pholcodine 5mg per 5ml Oral Solution, PL 03105/0059
Well Pharmaceuticals Pholcodine 5mg per 5ml Oral Solution, PL 03105/0059
Superdrug Pholcodine Linctus BP, PL 03105/0059
Strong Pholcodine Linctus BP, PL 03105/0060
Pholcodine Linctus BP, PL 04917/0002
Strong Pholcodine Linctus BP, PL 04917/0005
Pholcodine Linctus, PL 12965/0030
Day & Night Nurse Capsules, PL 44673/0068
Day Nurse Capsules, PL 44673/0069
Day Nurse, PL 44673/0075
– What should patients do?
Patients are being advised to tell their anaesthetist if they think they have taken pholcodine in the previous year and are about to undergo general anaesthetic.
The MHRA says people should also check products in their home (such as the packaging, label or patient information leaflet) to see if any contain pholcodine.
It said people can talk to their pharmacist about other suitable medications for relief from coughing.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments